Robert Aronowitz, a physician and historian at the University of Pennsylvania, has been elected to membership in the Institute of Medicine, one of the nation's highest honors in the health-care field.
Perelman School of Medicine
Blue light can both set the mood and set in motion important biological responses.
Patients with more severe psoriasis are also more likely to have uncontrolled hypertension, according to new research by a team at the Perelman School of Medicine at the University of Pennsylvania
Bruce Kinosian of the Perelman School of Medicine discusses house-call programs.
In multiple sclerosis, the immune system goes rogue, improperly attacking the body’s own central nervous system. Mobility problems and cognitive impairments may arise as the nerve cells become damaged.
University of Pennsylvania President Amy Gutmann and David L. Cohen, chair of Penn’s Board of Trustees, invite Penn students, faculty, staff, alumni, trustees and friends, as well as the region’s business and tech community, to a series of events from 12:30 to 4:30 p.m. on Friday, Oct.
A diagnosis of septic shock was once a near death sentence. At best, survivors suffered a substantially reduced quality of life.
Olaparib, an experimental twice-daily oral cancer drug, produces an overall tumor response rate of 26 percent in several advanced cancers associated with BRCA1 and BRCA2 mutations, according to new research co-led by the Abramson Cancer Center of the University of Pennsylvania.
Oncology researchers studying gene mutations in the childhood cancer neuroblastoma are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations. Removing some of the guesswork in diagnosis and treatment, the researchers say, may lead to more successful outcomes for children with this often-deadly cancer.